Literature DB >> 19758399

Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.

Matti Kontkanen, Leena Paimela, Kai Kaarniranta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19758399     DOI： 10.1111/j.1755-3768.2009.01546.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  9 in total

Review 1.  Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations.

Authors:  Buraa Kubaisi; Khawla Abu Samra; C Stephen Foster
Journal:  Intractable Rare Dis Res       Date:  2016-05

Review 2.  TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.

Authors:  Francisco Silva; Marcela Cisternas; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

3.  Rituximab for refractory granulomatous eye disease.

Authors:  Elyse E Lower; Robert P Baughman; Adam H Kaufman
Journal:  Clin Ophthalmol       Date:  2012-10-05

4.  Combined infliximab and rituximab in necrotising scleritis.

Authors:  Jiten Morarji; Lavnish Joshi; Oren Tomkins-Netzer; Sue Lightman; Simon R J Taylor
Journal:  Case Rep Ophthalmol       Date:  2012-09-11

5.  Use of biologic agents in ocular manifestations of rheumatic disease.

Authors:  Courtney L Kraus; Susan M Culican
Journal:  Int J Rheumatol       Date:  2011-12-15

Review 6.  Radiotherapy of granulomatosis with polyangiitis occurring in the eyelid: A case report and literature review.

Authors:  Jinlong Wei; Qin Zhao; Min Yao; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

7.  Low dose radiotherapy as an effective treatment in a patient with solitary Wegener's granulomatosis resistant to systemic treatment - case report.

Authors:  Andrzej Wygoda; Tomasz Rutkowski; Krzysztof Składowski; Beata Hejduk
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15

8.  Anti-cytokine targeted therapies for ANCA-associated vasculitis.

Authors:  Malgorzata M Bala; Teresa J Malecka-Massalska; Magdalena Koperny; Joanna F Zajac; Jarosław D Jarczewski; Wojciech Szczeklik
Journal:  Cochrane Database Syst Rev       Date:  2020-09-29

Review 9.  Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Authors:  Jurgen Sota; Matteo-Maria Girolamo; Bruno Frediani; Gian Marco Tosi; Luca Cantarini; Claudia Fabiani
Journal:  Ophthalmol Ther       Date:  2021-09-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.